11.95
1.13 (10.44%)
Market Trend
Short Term | Medium Term | ||
Industry | Health Information Services (US) | Bullish | Bearish |
Health Information Services (Global) | Bullish | Bearish | |
Stock | LifeMD, Inc. | Bullish | Bullish |
Analyst Consensus
5 Buy
Avg. Price @ Call: 8.88
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment. |
|
Sector | Healthcare |
Industry | Health Information Services |
Investment Style | Small Growth |
Ownership
Name | Date | Shares Held |
---|---|---|
Divisadero Street Capital Management, Lp | 31 Dec 2023 | 1,846,623 |
52 Weeks Range |
1.40 - 12.05
|
|
Price Target Range | ||
High | 15.00 (Craig-Hallum, 25.52%) | Buy |
Median | 12.00 (0.42%) | |
Low | 11.00 (Cantor Fitzgerald, -7.95%) | Buy |
Average | 12.80 (7.11%) | |
Total | 5 Buy |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
BTIG | 23 Apr 2024 | 14.00 (17.15%) | Buy | 10.89 |
15 Mar 2024 | 13.00 (8.79%) | Buy | 10.08 | |
B. Riley Securities | 12 Mar 2024 | 12.00 (0.42%) | Buy | 8.38 |
Cantor Fitzgerald | 12 Mar 2024 | 11.00 (-7.95%) | Buy | 8.38 |
Craig-Hallum | 12 Mar 2024 | 15.00 (25.52%) | Buy | 8.38 |
HC Wainwright & Co. | 12 Mar 2024 | 12.00 (0.42%) | Buy | 8.38 |
No data within this time range.
Date | Type | Details |
---|---|---|
29 Apr 2024 | Announcement | LifeMD Appoints Dr. Calum MacRae to its Board of Directors |
24 Apr 2024 | Announcement | LifeMD to Report First Quarter 2024 Financial Results on May 8 |
23 Apr 2024 | Announcement | LifeMD to Participate in Upcoming Investor and Industry Conferences During May |
26 Mar 2024 | Announcement | LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock |
25 Mar 2024 | Announcement | LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference |
11 Mar 2024 | Announcement | LifeMD Reports Fourth Quarter 2023 Results |
26 Feb 2024 | Announcement | LifeMD to Report Fourth Quarter 2023 Financial Results on March 11 |
15 Feb 2024 | Announcement | LifeMD to Participate in Upcoming Investor Conferences and Webinar |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |